Shares of Elan Corporation ELN are higher on the session by 2.43%, trading at $5.89.
Overall put volume is now running at 4.12x the daily average, with 63% of all puts traded being purchases on the offer. 1,503 contracts have traded on the session so far.
Elan Corporation, plc is a neuroscience-based biotechnology company. Elan's operations are organized into two business units: BioNeurology and Elan Drug Technologies
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in